Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Short-term Preoperative Diet Decreases Bleeding After Partial Hepatectomy: Results From a Multi-institutional Randomized Controlled Trial.

Barth RJ Jr, Mills JB, Suriawinata AA, Putra J, Tosteson TD, Axelrod D, Freeman R, Whalen GF, LaFemina J, Tarczewski SM, Kinlaw WB.

Ann Surg. 2019 Jan;269(1):48-52. doi: 10.1097/SLA.0000000000002709.

PMID:
29489484
2.

Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.

Moyer BJ, Rojas IY, Kerley-Hamilton JS, Hazlett HF, Nemani KV, Trask HW, West RJ, Lupien LE, Collins AJ, Ringelberg CS, Gimi B, Kinlaw WB 3rd, Tomlinson CR.

Toxicol Appl Pharmacol. 2016 Jun 1;300:13-24. doi: 10.1016/j.taap.2016.03.011. Epub 2016 Mar 25.

3.

Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.

Kinlaw WB, Baures PW, Lupien LE, Davis WL, Kuemmerle NB.

J Cell Physiol. 2016 Oct;231(10):2128-41. doi: 10.1002/jcp.25332. Epub 2016 Feb 16. Review.

4.

Inverse association between MDM2 and HUWE1 protein expression levels in human breast cancer and liposarcoma.

Canfield K, Wells W, Geradts J, Kinlaw WB, Cheng C, Kurokawa M.

Int J Clin Exp Pathol. 2016;9(6):6342-6349. Epub 2016 Jun 15.

5.

Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.

Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV, Smans K.

Prog Lipid Res. 2013 Oct;52(4):585-9. doi: 10.1016/j.plipres.2013.08.005. Epub 2013 Aug 31. Review.

6.

FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.

Danilova OV, Dumont LJ, Levy NB, Lansigan F, Kinlaw WB, Danilov AV, Kaur P.

J Hematop. 2013 Mar;6(1):11-18.

7.

A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.

McGowan MM, Eisenberg BL, Lewis LD, Froehlich HM, Wells WA, Eastman A, Kuemmerle NB, Rosenkrantz KM, Barth RJ Jr, Schwartz GN, Li Z, Tosteson TD, Beaulieu BB Jr, Kinlaw WB.

Breast Cancer Res Treat. 2013 Feb;138(1):175-83. doi: 10.1007/s10549-013-2446-9. Epub 2013 Feb 16.

8.

THRSP (thyroid hormone responsive).

Kuemmerle NB, Kinlaw WB.

Atlas Genet Cytogenet Oncol Haematol. 2011 Jun;15(6):480-482. No abstract available.

9.

Lipoprotein lipase links dietary fat to solid tumor cell proliferation.

Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, Pettus JR, Froehlich HM, Memoli VA, Morganelli PM, Swinnen JV, Timmerman LA, Chaychi L, Fricano CJ, Eisenberg BL, Coleman WB, Kinlaw WB.

Mol Cancer Ther. 2011 Mar;10(3):427-36. doi: 10.1158/1535-7163.MCT-10-0802. Epub 2011 Jan 31.

10.

A case report of a diabetic woman with very low HDL cholesterol.

Chaychi L, Kinlaw WB, Asztalos BF, Schaefer EJ.

J Clin Lipidol. 2010 Mar-Apr;4(2):133-5. doi: 10.1016/j.jacl.2010.01.003. Epub 2010 Jan 29. No abstract available.

PMID:
21122641
11.

Fatty acid synthesis is a therapeutic target in human liposarcoma.

Olsen AM, Eisenberg BL, Kuemmerle NB, Flanagan AJ, Morganelli PM, Lombardo PS, Swinnen JV, Kinlaw WB.

Int J Oncol. 2010 May;36(5):1309-14.

12.

Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvement.

Chaychi L, Chaidarun S, Golding A, Kinlaw WB, Memoli V, Siegel A.

Endocr Pract. 2010 May-Jun;16(3):463-7. doi: 10.4158/EP09325.CR.

PMID:
20061287
13.

Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.

Donnelly C, Olsen AM, Lewis LD, Eisenberg BL, Eastman A, Kinlaw WB.

Nutr Cancer. 2009;61(1):114-22. doi: 10.1080/01635580802348666.

14.

The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.

Hughes DT, Martel PM, Kinlaw WB, Eisenberg BL.

Cancer Invest. 2008 Mar;26(2):118-27. doi: 10.1080/07357900701522612.

15.

Long-term response of pituitary carcinoma to temozolomide. Report of two cases.

Fadul CE, Kominsky AL, Meyer LP, Kingman LS, Kinlaw WB, Rhodes CH, Eskey CJ, Simmons NE.

J Neurosurg. 2006 Oct;105(4):621-6.

PMID:
17044568
16.

Spot 14: A marker of aggressive breast cancer and a potential therapeutic target.

Kinlaw WB, Quinn JL, Wells WA, Roser-Jones C, Moncur JT.

Endocrinology. 2006 Sep;147(9):4048-55. Epub 2006 Jun 29. Review.

PMID:
16809441
17.

Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker.

Wells WA, Schwartz GN, Morganelli PM, Cole BF, Gibson JJ, Kinlaw WB.

Breast Cancer Res Treat. 2006 Jul;98(2):231-40. Epub 2006 Mar 22.

PMID:
16552628
18.

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.

Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.

Clin Endocrinol (Oxf). 2005 Dec;63(6):676-82.

PMID:
16343103
19.

S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth.

Martel PM, Bingham CM, McGraw CJ, Baker CL, Morganelli PM, Meng ML, Armstrong JM, Moncur JT, Kinlaw WB.

Exp Cell Res. 2006 Feb 1;312(3):278-88. Epub 2005 Nov 21.

PMID:
16300755
20.

Nondiabetic ketoacidosis caused by severe hyperthyroidism.

Wood ET, Kinlaw WB.

Thyroid. 2004 Aug;14(8):628-30.

PMID:
15320977
21.

Adiponectin and HIV-lipodystrophy: taking HAART.

Kinlaw WB, Marsh B.

Endocrinology. 2004 Feb;145(2):484-6. Review. No abstract available.

PMID:
14739152
22.

Amyloid goiter due to primary systemic amyloidosis: a diagnostic challenge.

Sinha RN, Plehn JF, Kinlaw WB.

Thyroid. 1998 Nov;8(11):1051-4.

PMID:
9848722
23.

"Spot 14" protein: a metabolic integrator in normal and neoplastic cells.

Cunningham BA, Moncur JT, Huntington JT, Kinlaw WB.

Thyroid. 1998 Sep;8(9):815-25. Review.

PMID:
9777755
24.
25.

Spot 14 protein-protein interactions: evidence for both homo- and heterodimer formation in vivo.

Cunningham BA, Maloney M, Kinlaw WB.

Endocrinology. 1997 Dec;138(12):5184-8.

PMID:
9389499
26.
27.

Assignment of the "spot 14" gene (THRSP) to human chromosome band 11q13.5 by in situ hybridization.

Moncur JT, Park JP, Maloney M, Mohandas TK, Kinlaw WB.

Cytogenet Cell Genet. 1997;78(2):131-2. No abstract available.

PMID:
9371405
28.

Direct evidence for a role of the "spot 14" protein in the regulation of lipid synthesis.

Kinlaw WB, Church JL, Harmon J, Mariash CN.

J Biol Chem. 1995 Jul 14;270(28):16615-8.

29.

Effect of selenium deficiency on type I 5'-deiodinase.

DePalo D, Kinlaw WB, Zhao C, Engelberg-Kulka H, St Germain DL.

J Biol Chem. 1994 Jun 10;269(23):16223-8.

31.
32.

Disappearance of muscular calcium deposits during resolution of prolonged rhabdomyolysis-induced hypercalcemia.

Lane JT, Boudreau RJ, Kinlaw WB.

Am J Med. 1990 Oct;89(4):523-5. No abstract available.

PMID:
2220885
34.
35.

Triiodothyronine rapidly reverses inhibition of S14 gene transcription by glucagon.

Kinlaw WB, Schwartz HL, Hamblin PS, Mariash CN, Oppenheimer JH.

Endocrinology. 1988 Nov;123(5):2255-60.

PMID:
3168921
36.
37.

Advances in our understanding of thyroid hormone action at the cellular level.

Oppenheimer JH, Schwartz HL, Mariash CN, Kinlaw WB, Wong NC, Freake HC.

Endocr Rev. 1987 Aug;8(3):288-308. Review. No abstract available.

PMID:
3308445
38.

Diurnal variation in hepatic expression of the rat S14 gene is synchronized by the photoperiod.

Kinlaw WB, Fish LH, Schwartz HL, Oppenheimer JH.

Endocrinology. 1987 Apr;120(4):1563-7.

PMID:
3830060
39.

Regulation of gene S-14 by triiodothyronine in liver.

Oppenheimer JH, Kinlaw WB, Wong NC, Schwartz HL, Mariash CN.

Horm Metab Res Suppl. 1987;17:1-5. Review. No abstract available.

PMID:
3327798
41.
42.

Hepatic messenger ribonucleic acid activity profiles in experimental azotemia in the rat. Relationship to food intake and thyroid function.

Kinlaw WB, Schwartz HL, Mariash CN, Bingham C, Carr FE, Oppenheimer JH.

J Clin Invest. 1984 Dec;74(6):1934-41.

43.

Abnormal zinc metabolism in type II diabetes mellitus.

Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ.

Am J Med. 1983 Aug;75(2):273-7.

PMID:
6881179
44.

Impotence in medical clinic outpatients.

Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, Nelson AE, Kinlaw WB, Beyer HS, Nuttall FQ, Shafer RB.

JAMA. 1983 Apr 1;249(13):1736-40.

PMID:
6827762
45.

Falsely localizing third-nerve palsy.

Jenkyn LR, Kinlaw WB, Bernat JL, Reeves AG.

N Engl J Med. 1980 Jul 17;303(3):161-2. No abstract available.

PMID:
7383083
46.

Azygos continuation of inferior vena cava: CT appearance.

Breckenridge JW, Kinlaw WB.

J Comput Assist Tomogr. 1980 Jun;4(3):392-7.

PMID:
7372870
47.

PARGYLINE HYDROCHLORIDE AND AMINE HYPERTENSION.

HUTCHISON JC, KINLAW WB, KRAVITZ B.

Angiology. 1965 Apr;16:187-202. No abstract available.

PMID:
14275865
48.

TRANYLCYPROMINE AND REACTION TO CHEESE.

HUTCHISON JC, KINLAW WB.

Curr Ther Res Clin Exp. 1964 Feb;6:127-9. No abstract available.

PMID:
14135296
49.

Indirect measurement of isovolumetric contraction time and tension period in normal subjects.

FRANK MN, KINLAW WB.

Am J Cardiol. 1962 Dec;10:800-6. No abstract available.

PMID:
13959244
50.

A controlled clinical comparison of guanethidine and trimethidinium methosulfate.

MOURY NF, KINLAW WB, DONAGHUE AH.

J Germantown Hosp. 1962 Feb;3:6-11. No abstract available.

PMID:
14476712

Supplemental Content

Loading ...
Support Center